← Eichor
Study identifier: NCT07497308 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

GDF-15 and Early Outcomes After LVAD Implantation

Condition: Advanced Heart Failure · Left Ventricular Assist Device Implantation  ·  Sponsor: Akdeniz University

PhaseN/A
Planned participants48
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This observational study aims to investigate the association between preoperative GDF-15 levels and early postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation. The study will evaluate whether elevated preoperative GDF-15 levels are associated with adverse early outcomes, including postoperative complications and mortality. The findings may help improve preoperative risk assessment and identify high-risk patients before LVAD implantation.

This description comes directly from the study's public registry record.

Talk to the study team

emel gündüz, md  ·  +902422496000  ·  dregunduz@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Akdeniz University, Faculty of Medicine, Department of Anesthesiology and ReanimationAntalya, Please Select:, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07497308